As tensions with Tehran escalate, Alma Center pundits urge drying up the supply of weapons to Shiite terror group; warn that ...

EDT Cathie Wood’s ARK Investment buys 255K shares of Cerus (CERS) today Published first on TheFly – the ultimate source for ...

On Friday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.7 which represents a slight increase of $0.07 or 4.29% from the prior close of $1.63. The stock opened at $1.63 and touched ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus (CERS – Research Report). The ...

Cerus (NASDAQ:CERS – Free Report) had its target price trimmed by Stifel Nicolaus from $6.00 to $3.00 in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has a buy ...

Cerus Corp (CERS) reports a 16% increase in product revenue and raises full-year guidance, despite challenges in government contracts and EU regulatory delays. The insider now owns 536,093 shares ...

Cerus Corp (CERS) reports a 16% increase in product revenue and raises full-year guidance, despite challenges in government ...

Transgene’s therapeutic cancer vaccine candidate has failed a mid-stage test in certain HPV-driven cancers, sending its ...

Australia’s transition to net zero is full steam ahead, but the energy grid now faces unprecedented changes in demand.

These pharmaceutical stocks have attractive dividends and valuation upside.

Cerus Corporation (Nasdaq: CERS) today announced a selection of abstracts to be presented at the 2024 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting, taking place in ...